![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
A new obesity biotech; UroGen aims to raise $107M
Plus, news about Otsuka, Ionis, Ability Biologics, Santhera, Mustang Bio and Vaxart:
New biotech joins obesity race: Supercede Therapeutics raised an undisclosed seed round from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.